8-K: Arcadia Biosciences Reports Strong Revenue Growth and Announces Business Combination with Roosevelt Resources
Earnings Release
Arcadia Biosciences announces a 56% increase in Q4 revenue and a business combination with Roosevelt Resources, highlighting growth in Zola coconut water sales and strategic asset sales.
Summary
- Arcadia Biosciences reported its financial results for the fourth quarter and full year of 2024.
- The company saw a 56% increase in revenue for Q4 and a 13% increase for the full year.
- Zola coconut water revenues increased by 124% in Q4 and 46% for the full year.
- Arcadia announced a business combination agreement with Roosevelt Resources, Inc.
- The company sold its Resistant Starch Durum trait to Corteva Agriscience for $4 million.
- Arcadia also sold its GoodWheat brand to Above Food Corp for $4 million in net payments over three years.
- The net loss attributable to common stockholders for 2024 was $7.1 million, compared to $14.0 million in 2023.
Sentiment
Score: 7
Explanation: The document presents a generally positive outlook due to revenue growth and strategic asset sales, but the net losses and pending business combination introduce some uncertainty.
Positives
- Significant revenue growth in Q4 and for the full year, driven by Zola coconut water sales.
- Strategic asset sales generated $4 million from Corteva and $4 million from Above Food Corp.
- Net loss attributable to common stockholders decreased from $14.0 million to $7.1 million year-over-year.
- Retail distribution for Zola nearly doubled in 2024.
- The company maintained tight cost controls, resulting in the lowest use of cash from operations since Arcadia went public.
Negatives
- Net loss attributable to common stockholders for the fourth quarter of 2024 was $4.1 million, compared to $2.8 million for the same period in 2023.
- The increase in net loss attributable to common stockholders for the fourth quarter of 2024 compared to the same period in 2023 was primarily driven by the change in the estimated fair value of common stock warrant and option liabilities.
Risks
- Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
- The company's future performance is subject to risks set forth in filings with the Securities and Exchange Commission.
- The business combination with Roosevelt Resources is subject to certain adjustments and regulatory approvals.
Future Outlook
The significant amount of new distribution added to Zola in the last six months of 2024 provides a tremendous amount of momentum for Arcadia as they enter 2025.
Management Comments
- We are extremely pleased with the progress we made in 2024, particularly in the second half of the year following the sale of our GoodWheatTM assets, said T.J. Schaefer, president and CEO.
- Our focus on Zola coconut water led to 80 percent revenue growth for the brand in the back half of the year and drove total Arcadia revenue growth above 30 percent.
- At the same time revenue growth was accelerating, we maintained tight cost controls, resulting in the lowest use of cash from operations since Arcadia went public a decade ago.
Industry Context
Arcadia's focus on plant-based health and wellness products aligns with growing consumer demand for healthier food options, positioning them well in the competitive food and beverage market.
Comparison to Industry Standards
- Comparing Arcadia's revenue growth to competitors in the plant-based beverage sector, such as Vita Coco, shows a similar trend of increasing demand for coconut water products.
- The sale of the GoodWheat brand to Above Food Corp mirrors the trend of larger companies acquiring smaller, innovative brands to expand their product portfolios.
- Arcadia's strategic shift towards high-margin products like Zola coconut water is a common strategy among smaller food companies to improve profitability.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President and Chief Executive Officer | Stan Jacot | Thomas J. Schaefer | July 2024 | Departure of Stan Jacot |
Stakeholder Impact
- Shareholders will be impacted by the proposed business combination with Roosevelt Resources, potentially owning approximately 10% of the outstanding shares post-closing.
- Employees may experience changes as a result of the business combination and leadership transition.
- Customers will continue to have access to Arcadia's plant-based health and wellness products, particularly Zola coconut water.
Next Steps
- Complete the business combination with Roosevelt Resources, Inc.
- Mail a definitive proxy statement/prospectus to the stockholders of Arcadia after the Registration Statement is declared effective by the SEC.
- Continue to focus on growing the Zola coconut water brand.
Key Dates
| Date | Description |
|---|---|
| December 4, 2024 | Arcadia, Roosevelt Resources, and other parties entered into a Securities Exchange Agreement. |
| December 6, 2024 | Arcadia filed a Report on Form 8-K regarding the Securities Exchange Agreement. |
| February 14, 2025 | Arcadia initially filed a Registration Statement on Form S-4. |
| March 20, 2025 | Arcadia Biosciences announced fourth-quarter and full-year 2024 financial results. |
| May 16, 2024 | Arcadia filed its definitive proxy statement for its 2024 annual meeting with the SEC. |
Keywords
Arcadia Biosciences, Roosevelt Resources, Zola coconut water, Financial results, Revenue growth, Business combination, Asset sales, RKDA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.